Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Product Format
freeze-dried
Storage Conditions
Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Section
Disclosure
This material is cited in a US or other Patent and may not be used to
infringe the claims. Depending on the wishes of the Depositor, ATCC may be
required to inform the Patent Depositor of the party to which the material was
furnished. This material may not have been produced or characterized by ATCC.
Preceptrol®
no
Type Strain
no
Medium
ATCC® Medium 3: Nutrient agar or nutrient broth
Growth Conditions
Temperature: 30°C
Atmosphere: Aerobic
Name of Depositor
Kayaku Antibiotics Research Laboratories
U.S. Patent Number
3,883,649
References
Nakajima N, et al. Gatavalin and process for producing same. US Patent 3,923,978 dated Dec 2 1975
J. Antibiot. Ser. A 3: 457-458, 1950.
Nakajima N, et al. A new antibiotic, gatavalin. I. Isolation and characterization. J. Antibiot. 25: 243-247, 1972. PubMed: 4559273
Ito M, Koyama Y. Jolipeptin, a new peptide antibiotic. I. Isolation, physico-chemical and biological characteristics. J. Antibiot. 25: 304-308, 1972. PubMed: 5042449
